Neurogene Inc. · NASDAQ:NGNE
Cvijic Christine Mikail sold 4,800 Neurogene Inc. shares (Form 4)
Traded Jul 1 to Jul 2, 2026 · Filed Jul 2, 2026
From Jul 1 to Jul 2, 2026, Cvijic Christine Mikail (Director, President and CFO) sold 4,800 Neurogene Inc. shares at an average US$34.71 for US$167K under a trading plan, leaving 88,840 shares. Filed Jul 2, 2026 (Form 4).
- Sold
- 4,800 shares
- Price
- US$34.71 average (US$34.06 to US$35.23)
- Value
- US$167K
- Holding after
- 88,840 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, President and CFO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Common Stock | Sale | 739 | US$34.06 | 92,901 | Direct |
| Jul 2, 2026 | Common Stock | Sale | 2,531 | US$34.58 | 90,370 | Direct |
| Jul 2, 2026 | Common Stock | Sale | 1,530 | US$35.23 | 88,840 | Direct |
Source
Related
- Neurogene Inc.
- Cvijic Christine Mikail
- Neurogene Inc. shareholders
- Form 4 · Cvijic Christine Mikail · Jul 7, 2026
- Form 4 · Cvijic Christine Mikail · May 8, 2026
- Schedule 13G · Prudential Financial Inc · Oct 7, 2026
- Schedule 13G · Jennison Associates LLC · Oct 6, 2026
- Form 4 · McMinn Rachel · Oct 2, 2026
- Schedule 13G/A · Redmile Group, LLC · Aug 14, 2026
- Schedule 13G · Balyasny Asset Management L.P. · Aug 14, 2026